
The Hancock™ II valve has stood the test of time. First introduced in the 1980s, it has been tested and studied, and earned the trust of cardiac surgeons around the world. After dozens of years of clinical experience and improvements along the way, Hancock II has demonstrated strong performance and durability in both aortic and mitral valve patients.1,2
Find more information, including other available configurations, for Hancock™ II bioprosthesis.